Organon & Co.

NYSE:OGN   9:46:40 AM EDT
10.52
+0.07 (+0.67%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.73B
Current PE3.91
Forward PE 2.75
2yr Forward PE 2.6
See more stats
Estimates Current Quarter
Revenue$1.57 Billion
Adjusted EPS$0.93
See more estimates
10-Day MA$10.33
50-Day MA$9.68
200-Day MA$12.07
See more pivots

Organon & Co. Stock, NYSE:OGN

30 Hudson Street, 33rd floor, Jersey City, New Jersey 07302
United States of America
Phone: +1.551.430.6900
Number of Employees: 10000

Description

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women�s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.